NP
CVS icon

NorthRock Partners’s CVS Health CVS Stock Holding History

NorthRock Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$783K Buy
7,569
+538
+8% +$48K 0.01% 349
2026
Q1 		$505K Buy
7,031
+3,493
+99% +$269K 0.01% 417
2025
Q4 		$281K Sell
3,538
-11,014
-76% -$868K ﹤0.01% 497
2025
Q3 		$1.1M Buy
14,552
+2,568
+21% +$176K 0.02% 325
2025
Q2 		$827K Sell
11,984
-2,253
-16% -$148K 0.02% 285
2025
Q1 		$965K Buy
+14,237
New +$852K 0.03% 216
2024
Q4 		– Sell
-12,481
Closed -$785K – 795
2024
Q3 		$785K Buy
12,481
+159
+1% +$9.28K 0.03% 256
2024
Q2 		$728K Sell
12,322
-5,513
-31% -$345K 0.03% 249
2024
Q1 		$1.42M Buy
17,835
+240
+1% +$18.3K 0.05% 156
2023
Q4 		$1.39M Buy
17,595
+9,288
+112% +$661K 0.06% 151
2023
Q3 		$580K Buy
8,307
+1,606
+24% +$114K 0.06% 138
2023
Q2 		$463K Buy
6,701
+1,854
+38% +$132K 0.05% 147
2023
Q1 		$360K Sell
4,847
-1,546
-24% -$130K 0.04% 191
2022
Q4 		$596K Sell
6,393
-762
-11% -$73.5K 0.07% 135
2022
Q3 		$682K Buy
7,155
+441
+7% +$43.7K 0.08% 113
2022
Q2 		$622K Buy
6,714
+115
+2% +$11.2K 0.06% 129
2022
Q1 		$668K Sell
6,599
-1,161
-15% -$122K 0.06% 144
2021
Q4 		$801K Buy
7,760
+1,258
+19% +$116K 0.06% 120
2021
Q3 		$552K Buy
6,502
+1,642
+34% +$138K 0.05% 151
2021
Q2 		$405K Buy
4,860
+599
+14% +$49.1K 0.03% 163
2021
Q1 		$321K Buy
4,261
+224
+6% +$16.3K 0.03% 167
2020
Q4 		$276K Buy
4,037
+475
+13% +$30.9K 0.03% 183
2020
Q3 		$208K Buy
3,562
+37
+1% +$2.3K 0.02% 210
2020
Q2 		$229K Sell
3,525
-297
-8% -$18.7K 0.03% 183
2020
Q1 		$227K Sell
3,822
-1,199
-24% -$80K 0.03% 170
2019
Q4 		$373K Sell
5,021
-274
-5% -$19.2K 0.04% 177
2019
Q3 		$334K Buy
+5,295
New +$314K 0.05% 153
2019
Q1 		– Sell
-4,219
Closed -$276K – 97
2018
Q4 		$276K Buy
+4,219
New +$315K 0.08% 68

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

NorthRock Partners's CVS Position: Q2 2026 in Review

NorthRock Partners increased its CVS Health (CVS) stake by 7.7% in Q2 2026, buying an estimated $48K and bringing the position to 7,569 shares worth $783K. The position accounts for 0.01% of the portfolio, ranked #349.

NorthRock Partners first reported a position in CVS in Q4 2018 and has held it in 28 quarters since. The position peaked at $1.42M in Q1 2024. 2,069 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • NorthRock Partners held 7,569 shares of CVS Health worth $783K as of Q2 2026.
  • NorthRock Partners bought 538 CVS Health shares in Q2 2026, an estimated $48K.
  • CVS Health made up 0.01% of NorthRock Partners's portfolio in Q2 2026, its #349 holding.
  • NorthRock Partners first reported a position in CVS Health in Q4 2018 and has held it in 28 quarters since.
  • NorthRock Partners's CVS Health position peaked at $1.42M in Q1 2024.
  • 2,069 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on NorthRock Partners's 13F filing for Q2 2026, filed 11 Aug 2026.